As key acetyltransferase family members and transcriptional co-activators, CREBBP/EP300 regulate the acetylation levels of multiple substrates involved in the regulation of normal hematopoietic maintenance and the development of hematological malignancies. The gene discussed is EP300; the disease is hematologic disorder.